Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Bank of Japan : (Research Paper) Impact of Macroprudential Policy Measures on Economic Dynamics

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/20/2013 | 08:28am CEST

: Simulation Using a Financial Macro-econometric Model

February 20, 2013
Hiroshi Kawata*
Yoshiyuki Kurachi**
Koji Nakamura***
Yuki Teranishi****

Abstract

This paper uses a financial macro-econometric model to compare and analyze the impact of macroprudential policy measures -- a credit growth restriction, loan-to-value and debt-to-income regulations, and a time-varying capital requirement -- on the economic dynamics through the financial cycle with the asset price bubble. Our analysis shows that although these macroprudential policy measures dampen economic volatility, it is possible that they reduce average economic growth, and the effects on the economic dynamics differ widely among macroprudential policy measures. In addition, the policy effects are changed dramatically by lags in recognizing the state of the economy. Our results also suggest that macroprudential policy measures can help contribute to more stable financial intermediation by raising the resilience of the financial system against risks.

In the course of writing this paper, we benefited from valuable comments offered by participants at seminars held by the ECB, BOE, IMF, FRB, and OFR and in the Research Institute for Economics and Business Administration - Kobe University workshop, and by Bank of Japan staff. We would like to express our deep appreciation for the comments. Any errors in this paper are naturally those of the authors. The views expressed here are those of the authors and should not be ascribed to the Bank of Japan or its Financial System and Bank Examination Department.

* Financial System and Bank Examination Department
E-mail : hiroshi.kawata@boj.or.jp
** Financial System and Bank Examination Department
E-mail : yoshiyuki.kurachi@boj.or.jp
*** Financial System and Bank Examination Department
E-mail : kouji.nakamura@boj.or.jp
**** Financial System and Bank Examination Department
E-mail : yuuki.teranishi@boj.or.jp
Notice

Papers in the Bank of Japan Working Paper Series are circulated in order to stimulate discussion and comments. Views expressed are those of authors and do not necessarily reflect those of the Bank.
If you have any comment or question on the working paper series, please contact each author.
When making a copy or reproduction of the content for commercial purposes, please contact the Public Relations Department (post.prd8@boj.or.jp) at the Bank in advance to request permission. When making a copy or reproduction, the source, Bank of Japan Working Paper Series, should explicitly be credited.

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news
Date Title
03:18a BRIXMOR PROPERTY GROUP : Prices Secondary Offering
03:13a IMAX USA : "A Beautiful Planet" tells beautiful tale of Earth
03:10a BHP BILLITON : 2015-16 Workplace Gender Equality Agency Report
03:10a ARGENT MINERALS : 30 Jun 2016 Additional Information – Presentation to Investors
03:10a EXTERRA RESOURCES : Widespread Gold Mineralisation at Hill East Prospect at Linden
03:10a RAWSON RESOURCES : PNG Exploration - Licence Award Update
03:08a FEDEX : Delivering the mail in the age of FedEx, email (VIDEO)
03:05a Asia share offerings plunge 60 percent in first half, seen pushing new job cuts
03:05a ARPENI PRATAMA OCEAN LINE TBK PT : The summary of minutes of meeting of annual general meeting of shareholders
03:05a GUIDEWIRE SOFTWARE : HSB Deploys Guidewire Systems for Underwriting, Policies, Billing and Data
Latest news
Advertisement
Hot News 
TESARO’s Niraparib Significantly Improved Progression-Free Survival for Patients With Ovarian Cancer in Both Cohorts of the Phase 3 NOVA Trial
Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitoring Committee Recommendation
BRAMMER : Share Price Halves On Profit Warning; May Scrap Interim Payout
DIAMOND RESORTS (DRII) ALERT : Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of Diamond Resorts International, Inc.; Is $30.25 a Fair Price?
ECLIPSE RESOURCES CORPORATION : Prices Public Offering of Common Stock
Most Read News
08:23p Asia stocks gain as post-Brexit bounce continues, yen pulls back
Most recommended articles
03:05aDJStocks Rise as Brexit Worries Ease
09:05p Asia share offerings plunge 60 percent in first half, seen pushing new job cuts
09:05pDJBrazil Court Accepts Telecom Oi Request for Bankruptcy Protection
08:37p UNITED OVERSEAS BANK : Singapore UOB says suspends London property loans programme
07:50p Toyota recalls 3.37 million cars over airbag, emissions control issues